Resilience provides mediating effect of resilience between fear of progression and sleep quality in patients with hematological malignancies

Table 3 Relationship between general patient data and patient resilience

Projects	Number, n (%)	Score	t/F	P value
Sex
Male	49 (49)	41.87 ± 7.08	-1.615	0.110
Female	51 (51)	39.62 ± 6.88
Age (yr)
≤ 35	34 (34)	41.94 ± 5.81	1.386	0.255
35-60	36 (36)	40.98 ± 6.73
≥ 60	30 (30)	39.05 ± 8.44
Marital status
Married	27 (27)	40.82 ± 6.23	0.877	0.419
Unmarried	48 (48)	41.48 ± 7.28
Divorce/widowhood	25 (25)	39.18 ± 7.40
Family per capita monthly income (RMB)
< 3000	32 (32)	33.56 ± 4.29	121.749	0.000
3000-5000	38 (38)	40.54 ± 2.96
> 5000	30 (30)	48.60 ± 4.16
Medical expenses payment method
Medical insurance	46 (46)	43.30 ± 6.68	2.231	0.113
Agricultural insurance	51 (51)	39.45 ± 7.21
Other	3 (3)	38.23 ± 5.98
Educational level
Junior high school and below	40 (40)	38.32 ± 7.23	7.744	0.001
High school/technical secondary school	41 (41)	40.84 ± 5.96
College degree or above	19 (19)	45.55 ± 6.52
Type of occupation
Employment	46 (46)	41.68 ± 6.96	-1.25	0.214
Unemployment	54 (54)	39.92 ± 7.07
Type of residence
Rural	34 (34)	40.58 ± 7.31	-0.147	0.883
Towns	66 (66)	40.80 ± 6.95
Disease course
Less than 2 yr	50 (50)	40.92 ± 7.11	0.277	0.782
2 yr and above	50 (50)	40.53 ± 7.03
Religious beliefs
Yes	5 (5)	40.50 ± 3.59	0.073	0.942
No	95 (95)	40.74 ± 7.18
Family history
Yes	16 (16)	40.79 ± 7.21	0.192	0.848
No	84 (84)	40.42 ± 6.23
Tumor type
Leukemia	29 (29)	39.67 ± 6.71	0.841	0.475
Lymphoma	30 (30)	39.92 ± 7.50
Multiple myeloma	21 (21)	41.90 ± 7.82
Myelodysplastic syndrome	20 (20)	42.23 ± 5.90